The effect of Yiqi Wenyang Huoxue Huatan Fang on hypoxia-hypercarbia induced pulmonary hypertension and its mechanism

doi:10.12047/j.cjap.5626.2018.093

Abstract

Abstract: Objective: To investigate the effect of Yiqi Wenyang Huoxue Huatan Fang (YWHHF) on alleviating hypoxia-hypercarbia pulmonary hypertension by inhibiting endothelial-mesenchymal transition (EndoMT) via BMP-7/Smads pathway. Methods: Fifty male healthy SD rats of clean grede, weighting (180~220) g, were randomly divided into 5 groups (n=10):normoxia group (N), hypoxia-hypercarbia group (HH); YWHHF high dose group (YH), middle dose group (YM) and low dose group (YL). The rats in N group were kept in normal oxygen environment, the remaining four groups were intermittently exposed to hypoxia-hypercarbia environment (9%~11% O₂, 5%~6% CO₂) for 4 weeks, 6 days a week, 8 hours per day. The rats in YH, YM, YL groups were received YWHHF gavage in a dosageof 0.6, 0.3, 0.15g/kg respectively (3 ml/kg),the rats in N and HH groups were received equal volume of normal saline. After 4 weeks, the mean pulmonary arterial pressure(mPAP) was detected,the right ventricular free wall and left ventricle plus ventricular septum were isolated to determine the right ventricular hypertrophy index. Lung ultrastructural changes were surveyed under an electronic microscopy, the changes of pulmonary artery structure surveyed by immunofluorescence, the mRNA levels of alpha-smooth muscle actin (α-SMA)、platelet endothelial cell adhesion molecule-1 (CD31)、bone morphogenetic protein-7 (BMP-7)、drosophila mothers against decapentaplegic protein1/5/8 (Smad1/5/8) were detected by RT-PCR, and the protein levels of α-SMA、CD31、BMP-7、p-Smad1/5/8 and Smad1/5/8 were detected by Western blot. Results: Compared with N group, mPAP and the right ventricular hypertrophy index were increased,some significant injuries also were discovered under microscopic observation,the mRNA and protein expression of α-SMA was increased, and the mRNA expressions of CD31、BMP-7、Smad1/5/8 were decreased in the other four groups, the protein expressions of CD31、BMP-7、p-Smad1/5/8 were decreased(P<0.05). Compared with HH group, the above changes in YH、YM、YL groups were all improved (P<0.05). Conclusion: YWHHF can inhibit EndoMT to alleviate pulmonary hypertension, and the mechanism may be related to the promotion of the expression of BMP-7/Smads pathway.

Key words: hypoxia and hypercapnia, BMP-7/Smads signaling pathway, EndoMT, pulmonary hypertension, rats

ZHANG Cong-cong, ZHANG Jing-jing, CHEN Jun-hao, WU Yuan-ling, HUANG Dan-na, DAI Yong-yue, WANG Wan-tie. The effect of Yiqi Wenyang Huoxue Huatan Fang on hypoxia-hypercarbia induced pulmonary hypertension and its mechanism[J]. CJAP, 2018, 34(5): 408-413.

References

[1] Kooperkamp H, Mehta I, Fary D, et al. Pulmonary thromboendarterectomy for pulmonary hypertension before considering transplant[J]. Ochsner J, 2017, 17(1):66-70.
[2] Reddy YN, Melenovsky V, Redfield MM, et al. High-output heart failure:a 15-year experience[J]. J Am Coll Cardiol, 2016, 68(5):473-482.
[3] Talwar A, Sahni S, Verma S, et al. Exercise tolerance improves after pulmonary rehabilitation in pulmonary hypertension patients[J]. J Exerc Rehabil, 2017, 13(2):214-217.
[4] Opitz CF, Hoeper MM, Gibbs JS, et al. Pre-capillary, combined, and post-capillary pulmonary hypertension:apathophysiological continuum[J]. J Am Coll Cardiol, 2016, 68(4):368-378.
[5] 朱阿楠, 王淑君, 王园园, 等. p38-MAPK信号通路在HHPH中的作用及三七总皂苷干预[J]. 中国应用生理学杂志, 2012, 28(1):79-84.
[6] Zhang H, Chang H, Wang LM, et al. Effect of polyelectrolyte film stiffness on endothelial cells during endothelial-to-mesenchymal transition[J]. Biomacromolecules, 2015, 16(11):3584-3593.
[7] Lin F, Wang N, Zhang TC. The role of endothelial-mesenchymal transition in development and pathological process[J]. IUBMB Life, 2012, 64(9):717-723.
[8] AktugDemir N, Kolgelier S, Inkaya AC, et al. Are bone morphogenetic protein-7(BMP-7) serum levels correlated with development of hepatic fibrosis[J]? J Infect Dev Ctries, 2014, 8(5):605-610.
[9] Mason RM. Fell-Muir lecture:connective tissue growth factor (CCN2)——a pernicious and pleiotropic player in the development of kidney fibrosis[J]. Int J Exp Pathol, 2013, 94(1):1-16.
[10] 赵美平, 缪初蕾, 张聪聪, 等. 川芎嗪注射液对慢性阻塞性肺疾病患者肺动脉高压的作用及其机制[J]. 中国应用生理学杂志, 2016, 32(5):408-412.
[11] DuBrock HM, Kradin RL, Rodriguez-Lopez JM, et al. Pulmonary capillary hemangiomatosis:the role of invasive cardiopulmonary exercise testing[J]. Pulm Circ, 2015, 5(3):580-586.
[12] 许益笑, 王园园, 贾旭广, 等. 内源性硫化氢体系与低O₂高CO₂性肺动脉高压的相关性研究[J]. 中国应用生理学杂志, 2011, 27(3):300-304.
[13] Ogawa E, Hori T, Doi H, et al. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension:Kyoto University experience[J]. Clin Transplant, 2014, 28(9):1031-1040.
[14] Ali MA, Tazmin T, Latif T, et al. Incomplete pentalogy of cantrell——acase report[J]. Mymensingh Med J, 2016, 25(1):153-157.
[15] Bajwa AA, Shujaat A, Patel M, et al. The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease[J]. PulmCirc, 2017, 7(1):82-88.
[16] Lee JC, Kim KC, Choe SY, et al. Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazinetreatment. Anat Cell Biol, 2016, 49(1):7-14.
[17] Roden AC, Yi ES. Pulmonary Langerhans cell histiocytosis:an update from the pathologists' perspective[J]. Arch Pathol Lab Med, 2016, 140(3):230-240.
[18] Suratt BT, Ubags NDJ, Rastogi D, et al. An official American thoracic society workshop report:obesity and metabolism. An emerging frontier in lung health and disease[J]. Ann Am ThoracSoc, 2017, 14(6):1050-1059.
[19] Masumoto K, de Rooij JD, Suita S, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development[J]. Histopathology, 2015, 47(4):410-419.
[20] 王淑君, 刘立宾, 黎关龙, 等. 三七皂苷单体R1抑制低氧高CO2诱导的肺动脉平滑肌细胞p38MAPK信号通路的活化[J]. 中国病理生理杂志, 2012, 28(1):105-108.
[21] Vasuri F, Resta L, Fittipaldi S, et al. RUNX-1 and CD44 as markers of resident stem cell derivation in undifferentiated intimal sarcoma of pulmonary artery[J]. Histopathology, 2012, 61(4):737-743.
[22] Han C, Hong KH, Kim YH, et al. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension[J]. Hypertension, 2013, 61(5):1044-1052.
[23] Kitao A, Sato Y, Sawada-Kitamura S, et al. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension[J]. Am J Pathol, 2009, 175(2):616-626.
[24] 刘雅洁, 孙小涵, 王洪海. 肺胀病的源流考及治法方药探析[J]. 中医临床研究, 2016, 8(10):37-39.
[25] 黄礼明. 试论痰、瘀、虚与COPD辨治关系[J]. 贵阳中医学院学报, 2000, 22(1):5.